Day 1 - Evening

Group 3A: HER2+ Breast Cancer; Biomarkers

Group 3B: HER2-low Breast Cancer; Biomarkers Last Few Tickets

Group 3C: HR+ Breast Cancer; Imaging; Immunotherapy Sold Out

Group 3D: HR+ Breast & Pan-Cancers; Sexual Health; Symptoms & Survivorship Sold Out

Group 3E: Triple Negative Breast Cancer; Healthcare Equity; Symptoms & Survivorship; Underserved Populations